Abstract 16655: Liver Fibrosis Severity is Associated with Congestive Heart Failure in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.16655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Shoubhit P A Nair und 3 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background - Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a systemic cardiometabolic disorder. Although cardiovascular disease is the leading cause of mortality in MASLD, the relationship between liver fibrosis severity and congestive heart failure (CHF) at the population level remains ill-defined. We evaluated the association between vibration-controlled transient elastography (VCTE)-derived liver stiffness and prevalent CHF among U.S. adults with MASLD. Methods - We performed a cross-sectional analysis of the National Health and Nutrition Examination Survey. MASLD was defined by hepatic steatosis (controlled attenuation parameter ≥274 dB/m) plus ≥1 cardiometabolic risk factor after exclusion of competing liver disease and significant alcohol use. Liver stiffness measurement (LSM) was analyzed continuously, by quartiles, and as advanced fibrosis (LSM ≥9.7 kPa). The primary outcome was self-reported CHF. Weighted multivariable logistic regression accounting for the complex NHANES design was performed. Results - Among 2,019 adults with MASLD, weighted CHF prevalence was 3.3% (n=88). Participants with CHF were older (68.0±9.4 vs 55.5±15.6 years; p
Zitieren
APA
Nair, S. P. A., Lalotra, T., Khankar, S., & Nadkarni, S. (2026). Abstract 16655: Liver Fibrosis Severity is Associated with Congestive Heart Failure in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.16655
Vancouver
Nair SPA, Lalotra T, Khankar S, Nadkarni S. Abstract 16655: Liver Fibrosis Severity is Associated with Congestive Heart Failure in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.16655
BibTeX
@article{Nair2026,
author = {Nair, Shoubhit P A and Lalotra, Tapesh and Khankar, Shreya and Nadkarni, Soham},
title = {Abstract 16655: Liver Fibrosis Severity is Associated with Congestive Heart Failure in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.16655}
}
EUVIMED